Bausch Health
BHC
#4743
Rank
โ‚น212.13 B
Marketcap
โ‚น567.21
Share price
1.55%
Change (1 day)
-1.19%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): -โ‚น275.90

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -โ‚น284.09. In 2025 the company made an earnings per share (EPS) of โ‚น40.45 an increase over its 2024 EPS that were of -โ‚น11.56.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น275.90-782.15%
2025โ‚น40.45-450%
2024-โ‚น11.56-92.59%
2023-โ‚น156.01160.89%
2022-โ‚น59.80-76.64%
2021-โ‚น255.9668.45%
2020-โ‚น151.95-68.91%
2019-โ‚น488.72-57.11%
2018-โ‚น1,140-272.22%
2017โ‚น661.69-199.29%
2016-โ‚น666.40798.7%
2015-โ‚น74.15-128.31%
2014โ‚น261.94-204.62%
2013-โ‚น250.38602.7%
2012-โ‚น35.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-โ‚น8.67-96.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น91.49-67.80%๐Ÿ‡บ๐Ÿ‡ธ USA